�ڰ�������

reducing stillbirth (First PLUS) receives Phase 2 National Institute for Health Research (NIHR) Award

New publication: Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis

New Partnership between Marubeni/Clairvo and �ڰ������� to bring LiverMultiScan to Japan

�ڰ������� Partners in a New Study in Singapore for the Early Detection of Liver Cancer using Precision Medicine

New Study Shows Measurable Organ Impairment in Long COVID Patients

�ڰ������� Appoints Annalisa Jenkins, MBBS, FRCP to Board of Directors

High Liver Fat (Hepatic Steatosis) Linked to Increased Risk of Hospitalization in COVID-19 Patients with Obesity

LiverMultiScan shown to be the best non-invasive predictor of disease activity in autoimmune hepatitis, demonstrating its potential to influence clinical treatment.

�ڰ������� Lands Top Spot in Alantra Pharma Fast 50 Rankings